Table 2. . TACE procedures.
| Doxorubicin dose | |
|---|---|
| Successful administration of total dose, % (n) | 88% (44/50) |
| Dose (mg), mean ± SD (n) | 79.2 ± 15.9 (47/50) |
| Cumulative dose across all procedures | |
| Dose (mg), mean ± SD (n) | 174.4 ± 80.2 (49/50) |
| Number of procedures per patient, % (n) | |
| 1 DEM-TACE procedure | 28.0 (14/50) |
| 2 DEM-TACE procedures | 24.0 (12/50) |
| ≥3 DEM-TACE procedures | 48.0 (24/50) |
| Median number of TACE procedures (range) | 2.0 (1.00–6.00) |
| Size of microspheres, % (n) | |
| 200 μm | 18.0 (9/50) |
| 400 μm | 82.0% (41/50) |
DEM-TACE: Drug-eluting microsphere transarterial chemoembolization; TACE: Transarterial chemoembolization.